Charles R. Kummeth's most recent trade in Quantum-Si Incorporated - Ordinary Shares - Class A was a trade of 126,095 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quantum-Si Incorporated - ... | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 126,095 | 126,095 | - | - | Stock Option (right to buy) | |
| Gentherm Inc - Ordinary Sh... | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 5,075 | 21,645 (0%) | 0% | 0 | Common Stock | |
| Quantum-Si Incorporated - ... | Charles R. Kummeth | Director | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 09 Aug 2024 | 138,900 | 323,900 | - | 0.9 | 120,926 | Class A Common Stock |
| Quantum-Si Incorporated - ... | Charles R. Kummeth | Director | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 09 Aug 2024 | 31,100 | 355,000 | - | 0.9 | 27,533 | Class A Common Stock |
| Orthofix Medical Inc | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 12.87 per share. | 18 Jun 2024 | 15,152 | 38,502 (0%) | 0% | 12.9 | 195,006 | Common Stock |
| Quantum-Si Incorporated - ... | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 113,281 | 113,281 | - | - | Stock Option (Right to buy) | |
| Quantum-Si Incorporated - ... | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 527,777 | 527,777 | - | - | Stock Option (Right to buy) | |
| Gentherm Inc - Ordinary Sh... | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 2,662 | 16,570 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 13.89 per share. | 31 Jan 2024 | 8,350 | 23,350 (0%) | 0% | 13.9 | 115,982 | Common Stock |
| Orthofix Medical Inc | Kummeth Charles R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 47,652 | 47,652 | - | - | Stock Option (right to buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 59,095 | 59,095 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 17,632 | 1,286,944 (3%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.61 per share. | 15 Aug 2023 | 8,675 | 1,278,269 (3%) | 0% | 84.6 | 733,992 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Aug 2023 | 9,008 | 1,269,312 (3%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2023 | 51,516 | 1,310,282 (3%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2023 | 51,516 | 0 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.17 per share. | 05 Aug 2023 | 31,962 | 1,278,320 (3%) | 0% | 82.2 | 2,626,318 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 88.36 per share. | 21 Jul 2023 | 80,000 | 1,258,766 (3%) | 0% | 88.4 | 7,069,024 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 616,676 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.65 per share. | 30 Jun 2023 | 616,676 | 1,729,493 (4%) | 1% | 26.6 | 16,434,415 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.63 per share. | 30 Jun 2023 | 390,727 | 1,338,766 (3%) | 1% | 81.6 | 31,895,045 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 83.00 per share. | 07 Jun 2023 | 322 | 1,112,817 (2%) | 0% | 83 | 26,726 | Common Stock |
| Gentherm Inc - Ordinary Sh... | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,147 | 13,908 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.65 per share. | 04 Jan 2023 | 407,364 | 1,368,976 (3%) | 1% | 26.7 | 10,856,251 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 407,364 | 616,676 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.39 per share. | 04 Jan 2023 | 255,837 | 1,113,139 (2%) | 0% | 84.4 | 21,590,084 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 13,225 | 13,225 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2022 | 16,937 | 0 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2022 | 16,918 | 251,960 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 382.97 per share. | 07 Aug 2022 | 11,557 | 240,403 (0%) | 0% | 383.0 | 4,425,984 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2022 | 45,346 | 0 | - | - | Stock Option (right to buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.49 per share. | 28 Jul 2022 | 45,346 | 262,749 (0%) | 0% | 108.5 | 4,919,588 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 380.76 per share. | 28 Jul 2022 | 27,707 | 235,042 (0%) | 0% | 380.8 | 10,549,717 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2022 | 50,000 | 45,346 | - | - | Stock Option (right to buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.49 per share. | 06 Jul 2022 | 50,000 | 248,338 (0%) | 0% | 108.5 | 5,424,500 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 362.78 per share. | 06 Jul 2022 | 30,935 | 217,403 (0%) | 0% | 362.8 | 11,222,599 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 5,104 | 95,346 | - | - | Stock Option (right to buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 365.00 per share. | 07 Jun 2022 | 5,104 | 198,338 (0%) | 0% | 365 | 1,862,960 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.49 per share. | 07 Jun 2022 | 5,104 | 203,442 (0%) | 0% | 108.5 | 553,733 | Common Stock |
| Gentherm Inc - Ordinary Sh... | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 1,700 | 11,761 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.59 per share. | 28 Jan 2022 | 938 | 197,539 (0%) | 0% | 106.6 | 99,981 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 938 | 256,010 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.05 per share. | 28 Jan 2022 | 799 | 198,338 (0%) | 0% | 125.1 | 99,915 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 799 | 194,771 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.49 per share. | 02 Sep 2021 | 73,492 | 238,606 (0%) | 0% | 108.5 | 7,973,147 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 73,492 | 100,450 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.78 per share. | 02 Sep 2021 | 42,005 | 196,601 (0%) | 0% | 510.8 | 21,455,314 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 921 | 173,942 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.49 per share. | 11 Aug 2021 | 921 | 165,114 (0%) | 0% | 108.5 | 99,919 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 31,315 | 31,315 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 20,876 | 20,876 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 16,918 | 176,668 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 16,918 | 0 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 481.82 per share. | 06 Aug 2021 | 12,475 | 164,193 (0%) | 0% | 481.8 | 6,010,705 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 8,016 | 8,016 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 5,344 | 159,750 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 449.35 per share. | 17 Jun 2021 | 6,732 | 160,172 (0%) | 0% | 449.3 | 3,025,024 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 449.09 per share. | 17 Jun 2021 | 2,583 | 154,732 (0%) | 0% | 449.1 | 1,159,999 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 450.39 per share. | 17 Jun 2021 | 1,698 | 158,474 (0%) | 0% | 450.4 | 764,762 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 451.54 per share. | 17 Jun 2021 | 1,050 | 157,424 (0%) | 0% | 451.5 | 474,117 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 450.37 per share. | 17 Jun 2021 | 326 | 154,406 (0%) | 0% | 450.4 | 146,821 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 452.13 per share. | 17 Jun 2021 | 109 | 157,315 (0%) | 0% | 452.1 | 49,282 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 449.10 per share. | 14 Jun 2021 | 7,132 | 167,253 (0%) | 0% | 449.1 | 3,202,981 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 450.10 per share. | 14 Jun 2021 | 349 | 166,904 (0%) | 0% | 450.1 | 157,085 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.35 per share. | 25 May 2021 | 36,849 | 195,690 (0%) | 0% | 94.3 | 3,476,703 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2021 | 36,849 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 420.12 per share. | 25 May 2021 | 21,305 | 174,385 (0%) | 0% | 420.1 | 8,950,657 | Common Stock |
| Gentherm Inc - Ordinary Sh... | Charles R. Kummeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 1,422 | 10,061 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 30,000 | 36,849 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.35 per share. | 16 Feb 2021 | 30,000 | 176,269 (0%) | 0% | 94.4 | 2,830,500 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 411.00 per share. | 16 Feb 2021 | 17,428 | 158,841 (0%) | 0% | 411 | 7,162,908 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 344.00 per share. | 15 Jan 2021 | 20,000 | 146,269 (0%) | 0% | 344 | 6,880,000 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2020 | 25,157 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.25 per share. | 06 Nov 2020 | 25,157 | 186,644 (0%) | 0% | 86.2 | 2,169,791 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 302.47 per share. | 06 Nov 2020 | 15,375 | 171,269 (0%) | 0% | 302.5 | 4,650,476 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2020 | 21,291 | 0 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2020 | 21,291 | 173,774 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 265.76 per share. | 09 Aug 2020 | 12,287 | 161,487 (0%) | 0% | 265.8 | 3,265,393 | Common Stock |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 57,442 | 57,442 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 38,295 | 38,295 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 16,650 | 16,650 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 16,650 | 16,650 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 12,879 | 12,879 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | Charles R. Kummeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 8,586 | 152,483 (0%) | 0% | 0 | Common Stock |